Howard A. Fine, M.D.
Neuro Oncology Branch
Branch Chief
National Cancer Institute
9030 Old Georgetown Road
Building 82, Room 235
Bethesda, MD 20892
Phone: 301-402-6383
Fax: 301-480-2246
hfine@mail.nih.gov
Dr. Fine is currently chief of the Neuro-Oncology Branch at NCI’s Center for Cancer Research, and of the National Institute of Neurologic Disorders and Stroke. He received his B.A. from the University of Pennsylvania, Philadelphia, and his M.D. from Mount Sinai School of Medicine, New York. Dr. Fine completed both his internship and his residency in internal medicine at the Hospital of The University of Pennsylvania. Three years later he completed his fellowship in medical oncology at Harvard Medical School’s Dana-Farber Cancer Institute, Boston, MA. Before joining the NIH in 2000, Dr. Fine was both director of the Neuro-Oncology Disease Center at the Dana-Farber Cancer Institute, and of the Neuro-Oncology Program at the Harvard Cancer Center. The NCI senior investigator serves on several committees, including the Brain Tumor Program Review Group and the American Joint Committee on Cancer. Dr. Fine also serves on the editorial boards of several journals, including the Journal of Clinical Oncology, Neuro-Oncology, and The Oncologist. He has received several distinguished awards, including the Dana-Farber Harvard Cancer Center’s Clinical Investigator Award in 1999, the Emil Frei III Clinical Investigator Award in 1993, and the Brain Tumor Society Research Award in 1992. His research interests include tumor angiogenesis, therapeutic gene transfer, and neural stem cell biology.
Dr. Fine's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with brain and central nervous system tumors. Click on the trial(s) below for additional details, including a summary of eligibility criteria, study outline, and information on how to contact the study team directly.
Back to Top
